---
$id: https://graph.org.ai/products/commodity/51142414
$type: Product
source: UNSPSC
code: "51142414"
title: "Sumatriptan"
class: "51142400"
classTitle: "Drugs used for vascular and migraine headaches"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Sumatriptan

**UNSPSC Code**: 51142414
**Class**: [Drugs used for vascular and migraine headaches](Drugs used for vascular and migraine headaches.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a serotonin agonist with the molecular formula C14H21N3O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8R78F6L9VO, chemically known as 1h-indole-5-methanesulfonamide, 3-(2-(dimethylamino)ethyl)-n-methyl- but generally known as sumatriptan, which bears US NIH Compound Identifier 5358. European Medicines Agency schedules Sumatriptan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10770MIG. The term SUMATRIPTAN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, No. 3, 1989, List 29). World Health Organization schedules sumatriptan in its Anatomical Therapeutic Chemical (ATC) Classification. SUMATRIPTAN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule sumatriptan under HS 29350090 and SITC 51580. As of Q4 2014, SUMATRIPTAN remains the US FDA Preferred Term for this commodity. Sumatriptan bears US NLM identifiers UMLS ID C0075632 and NCI Concept Code C1240. SMILES: S(=O)(=O)(NC)CC1CC2C(CCN(C)C)C[NH]C2CC1.

